Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Baricitinib for Patients with Relapsing or Naïve Dermatomyositis
FranceTreatment Study of Diabetic Foot Ulcers Using Autologous Stromal Vascular Fraction Cells for Patients with Non-healing Wounds
FranceStudy on the Safety and Effects of Pegunigalsidase Alfa for Children and Adolescents with Fabry Disease
AustriaStudy on the Safety and Effectiveness of CABA-201, Fludarabine Phosphate, and Cyclophosphamide in Patients with Active Systemic Lupus Erythematosus
FranceStudy of Regorafenib with BRAF/MEK-Inhibitor Combination for Patients with Advanced Melanoma After Previous Treatment
BelgiumStudy on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
BulgariaStudy on the Safety and Immune Response of Shingrix Vaccine in Patients with Psoriasis or Psoriatic Arthritis
GermanyStudy of Vemurafenib, Cobimetinib, and Atezolizumab for Patients with High-Risk, Surgically Removable BRAF Mutated and Wild-Type Melanoma
ItalyStudy on Morning vs. Evening Dosing of Tofacitinib for Patients with Rheumatoid or Psoriatic Arthritis
The NetherlandsImaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis
The NetherlandsStudy on Upadacitinib for Patients with Idiopathic Inflammatory Myopathies After Stopping IVIG
AustriaStudy on the Effectiveness and Safety of Etanercept for Patients with SAPHO Syndrome
PolandThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
